Elekta AB (publ) 最近的每股盈餘為 $0.55,{eisBeating} $1.44 的預期。
Elekta AB (publ) EKTAY 上一季度的收入表現如何?
Elekta AB (publ) 上一季度的收入為 $0.55
Elekta AB (publ) 的收入預期是多少?
根據 3 位華爾街分析師的預測,Elekta AB (publ) 的收入預期範圍從 $3.94B 到 $3.33B
Elekta AB (publ) 的盈利品質評分是多少?
Elekta AB (publ) 的盈利品質評分為 /。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Elekta AB (publ) 何時發布財報?
Elekta AB (publ) 的下一份財報預計在 2026-08-26 發布
Elekta AB (publ) 的預期收益是多少?
根據華爾街分析師的預測,Elekta AB (publ) 的預期收益為 $5.0B
Elekta AB (publ) 是否超出收益預期?
Elekta AB (publ) 最近的收益為 $4.84B,未達預期 預期。
關鍵數據
前收市價
$5.06
開盤價
$5.06
當日範圍
$5.03 - $5.06
52週區間
$4.35 - $6.93
交易量
2
平均成交量
1.7K
股息收益率
--
每股盈餘 (TTM)
-0.14
市值
$1.8B
什麼是 Elekta AB?
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The firm provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.